Oncotarget – Great Strides In Oncology And Cancer Research Papers

Oncotarget is a free content traditional journal that covers a wide array of oncology and certain aspects of aging, lymphocytes, neurodegeneration, neurons, and more. They publish these research papers online, on a weekly basis. Oncotarget publishes oncology and cancer research papers presented to them, as well as research papers on endocrinology, physiology, pathology, immunology, and diseases linked to certain ages, young and old. Oncotarget has other areas of research papers. There are sections of Advisory and Editorial Boards dealing with many fields of study including all fields of pathology, in or outside of oncology, including immunology, chromosomes, cell disease, and other related fields of study.

If you are interested in submitting research papers, in any of these sections of oncology or science, select a section relating to your research paper in order to submit the research to Oncotarget. If no field is related to your research, just choose “other”. If submitting an editorial, select “Editorial”, no matter the subject. Oncotarget is ranked highest in total documents within all Oncology journals for 2015 through 2016 in the USA, with 6391 documents.Oncotarget has a main mission along with these secondary missions.To quickly attain good scientific results and make them rapidly available to a wide audience, to make a great impact with the presented research papers.

Using a perceptive reappraisal, and permit the exceedingly exceptional research papers to be shared quickly and, to get rid of the boundaries among specialties in order to connect the various biomedical and science fields and to nurture diligence of chemical and basic science to combat disease. Oncotarget’s main mission is to achieve a life without disease.This Journal aids researchers in contributing to science’s progress, with the help of prominent scientists’ guidance and leadership. There are currently more than 250 research papers available from the Editorial Board. Oncotarget’s success has allowed them to launch other sections outside of oncology, bringing them closer to their main goal, a disease free life.